▶ 調査レポート

世界の調剤薬局市場

• 英文タイトル:Market Study on Compounding Pharmacies: Rising Popularity of Customized Medications to Bode Well for Market Growth

Market Study on Compounding Pharmacies: Rising Popularity of Customized Medications to Bode Well for Market Growth「世界の調剤薬局市場」(市場規模、市場予測)調査レポートです。• レポートコード:PMR2201A059
• 出版社/出版日:Persistence Market Research / 2021年12月20日
• レポート形態:英文、PDF、245ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥622,300 (USD4,900)▷ お問い合わせ
  Site Licence¥965,200 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,346,200 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートは、世界の調剤薬局市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の影響分析、市場需要分析/予測、製品別(経口薬カプセル、局所薬、うがい薬、坐剤)分析、用途別(大人用、動物用、子供用、高齢者用)分析、治療別(疼痛管理、ホルモン補充治療)分析、地域別分析、主要国分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・主要成功要因
・市場背景
・新型コロナウイルス感染症の影響分析
・市場需要分析/予測
・世界の調剤薬局市場規模:製品別(経口薬カプセル、局所薬、うがい薬、坐剤)
・世界の調剤薬局市場規模:用途別(大人用、動物用、子供用、高齢者用)
・世界の調剤薬局市場規模:治療別(疼痛管理、ホルモン補充治療)
・世界の調剤薬局市場規模:地域別
・主要国分析
・市場構造分析
・競争分析
・仮定
・調査手法

Compounding Pharmacies Market – Scope of Report

The latest publication by Persistence Market Research on the compounding pharmacies market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for compounding pharmacies market and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the compounding pharmacies market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the compounding pharmacies market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the compounding pharmacies market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments
Persistence Market Research’s study on the compounding pharmacies market offers information divided into five important segments — product, application, therapeutic area, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product
Oral Medication Capsules
Tablets
Mixtures
Lollipops
Lozenges
Topical Medication
Gels
Ointments
Cream
Lotions
Mouthwashes
Suppositories

Application
Medication for Adults
Veterinary Medication
Medication for Children
Geriatric Medication

Therapeutic Area
Pain Management
Hormone Replacement Therapy

Region
North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)

Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for compounding pharmacies over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the compounding pharmacies market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the compounding pharmacies market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the compounding pharmacies market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Analysis and Recommendations

1.3. Wheel of Fortune

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Trends in Diverse Applications

4. Key Success Factors

4.1. Product Type Adoption Rate/Usage Analysis- Key Statistics

4.2. Key Regulations, by Region

4.3. PEST Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Healthcare Industry Market Outlook

5.1.3. Income Per Capita Outlook

5.2. Forecast Factors – Relevance & Impact

5.2.1. Increasing Medicinal Droughts of Prescription Medicine

5.2.2. Growing demand for HRT drugs

5.2.3. Examples of Upcoming HRTs

5.2.4. Pain Management Therapies are Driving the Growth of the Market

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

6.1. Current COVID19 Probable Future Impact

6.2. Current GDP Projection and Probable Impact

6.3. Current Economic Projection as compared to 2008 Economic analysis

6.4. COVID19 and Impact Analysis

6.4.1.1. Revenue By Product

6.4.1.2. Revenue By Application

6.4.1.3. Revenue By Therapeutic Area

6.4.1.4. Revenue By Country

6.5. 2020 Market Scenario

6.6. Recovery Scenario – Short term, Midterm and Long Term Impact

7. Global Compounding Pharmacies Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, by Product

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Product, 2016-2020

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2021-2031

8.3.1. Oral Medication Capsule

8.3.1.1.1. Tablets

8.3.1.1.2. Mixtures

8.3.1.1.3. Lollipops

8.3.1.1.4. Lozenges

8.3.2. Topical Medication

8.3.2.1.1. Gels

8.3.2.1.2. Ointments

8.3.2.1.3. Cream

8.3.2.1.4. Lotions

8.3.3. Mouthwashes

8.3.4. Suppositories

8.4. Market Attractiveness Analysis By Product

9. Global Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, by Application

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Application, 2016 – 2020

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2021 – 2031

9.3.1. Medication For Adults

9.3.2. Medication for Veterinary

9.3.3. Medication for Children

9.3.4. Medication for Geriatric

9.4. Market Attractiveness Analysis By Application

10. Global Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031, by Therapeutic Area

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Therapeutic Area, 2016 – 2020

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapeutic Area, 2021 – 2031

10.3.1. Pain Management

10.3.2. Hormone Replacement Therapy

10.4. Market Attractiveness Analysis By Application

11. Global Compounding Pharmacies Market 2016-2020 and Forecast 2021-2031, by Region

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2020

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. South Asia

11.3.5. East Asia

11.3.6. Oceania

11.3.7. Middle East & Africa

11.4. Market Attractiveness Analysis By Region

12. North America Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

12.3. Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031

12.3.1. By Country

12.3.1.1.1. U.S.

12.3.1.1.2. Canada

12.3.2. By Product

12.3.3. By Application

12.3.4. By Therapeutic Area

12.4. Market Attractiveness Analysis

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. Latin America Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

13.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Market Taxonomy, 2021-2031

13.3.1. By Country

13.3.1.1. Brazil

13.3.1.2. Mexico

13.3.1.3. Argentina

13.3.1.4. Rest of Latin America

13.3.2. By Product

13.3.3. By Application

13.3.4. By Therapeutic Area

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Europe Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

14.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Market Taxonomy, 2021-2031

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. Italy

14.3.1.3. France

14.3.1.4. U.K.

14.3.1.5. Spain

14.3.1.6. BENELUX

14.3.1.7. Russia

14.3.1.8. Rest of Europe

14.3.2. By Product

14.3.3. By Application

14.3.4. By Therapeutic Area

14.4. Market Attractiveness Analysis

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. South Asia Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Thailand

15.3.1.3. Indonesia

15.3.1.4. Malaysia

15.3.1.5. Rest of South Asia

15.3.2. By Product

15.3.3. By Application

15.3.4. By Therapeutic Area

15.4. Market Attractiveness Analysis

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. East Asia Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031

16.3.1. By Country

16.3.1.1. China

16.3.1.2. Japan

16.3.1.3. South Korea

16.3.2. By Product

16.3.3. By Application

16.3.4. By Therapeutic Area

16.4. Market Attractiveness Analysis

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. Oceania Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

17.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Market Taxonomy, 2021-2031

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. By Product

17.3.3. By Application

17.3.4. By Therapeutic Area

17.4. Market Attractiveness Analysis

17.5. Key Market Participants – Intensity Mapping

17.6. Drivers and Restraints – Impact Analysis

18. Middle East and Africa Compounding Pharmacies Market Analysis 2016-2020 and Forecast 2021-2031

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

18.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Market Taxonomy, 2021-2031

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. Turkey

18.3.1.3. Northern Africa

18.3.1.4. South Africa

18.3.1.5. Rest of Middle East and Africa

18.3.2. By Product

18.3.3. By Application

18.3.4. By Therapeutic Area

18.4. Market Attractiveness Analysis

18.5. Key Market Participants – Intensity Mapping

18.6. Drivers and Restraints – Impact Analysis

19. Key and Emerging Countries Compounding Pharmacies Market Analysis 2021 & 2031

19.1. Introduction

19.1.1. Market Value Proportion Analysis, By Key Countries

19.1.2. Global Vs. Country Growth Comparison

19.2. U.S. Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.2.1. By Product

19.2.2. By Application

19.2.3. By Therapeutic Area

19.3. Canada Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.3.1. By Product

19.3.2. By Application

19.3.3. By Therapeutic Area

19.4. Mexico Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.4.1. By Product

19.4.2. By Application

19.4.3. By Therapeutic Area

19.5. Brazil Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.5.1. By Product

19.5.2. By Application

19.5.3. By Therapeutic Area

19.6. Argentina Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.6.1. By Product

19.6.2. By Application

19.6.3. By Therapeutic Area

19.7. U.K. Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.7.1. By Product

19.7.2. By Application

19.7.3. By Therapeutic Area

19.8. Germany Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.8.1. By Product

19.8.2. By Application

19.8.3. By Therapeutic Area

19.9. France Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.9.1. By Product

19.9.2. By Application

19.9.3. By Therapeutic Area

19.10. Italy Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.10.1. By Product

19.10.2. By Application

19.10.3. By Therapeutic Area

19.11. Spain Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.11.1. By Product

19.11.2. By Application

19.11.3. By Therapeutic Area

19.12. BENELUX Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.12.1. By Product

19.12.2. By Application

19.12.3. By Therapeutic Area

19.13. Russia Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.13.1. By Product

19.13.2. By Application

19.13.3. By Therapeutic Area

19.14. China Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.14.1. By Product

19.14.2. By Application

19.14.3. By Therapeutic Area

19.15. Japan Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.15.1. By Product

19.15.2. By Application

19.15.3. By Therapeutic Area

19.16. South Korea Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.16.1. By Product

19.16.2. By Application

19.16.3. By Therapeutic Area

19.17. India Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.17.1. By Product

19.17.2. By Application

19.17.3. By Therapeutic Area

19.18. ASEAN Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.18.1. By Product

19.18.2. By Application

19.18.3. By Therapeutic Area

19.19. Australia Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.19.1. By Product

19.19.2. By Application

19.19.3. By Therapeutic Area

19.20. New Zealand Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.20.1. By Product

19.20.2. By Application

19.20.3. By Therapeutic Area

19.21. GCC Countries Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.21.1. By Product

19.21.2. By Application

19.21.3. By Therapeutic Area

19.22. Turkey Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.22.1. By Product

19.22.2. By Application

19.22.3. By Therapeutic Area

19.23. South Africa Compounding Pharmacies Market Value (US$) Analysis, 2021 & 2031

19.23.1. By Product

19.23.2. By End User

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies

20.2. Market Concentration

20.3. Company Share Analysis

21. Competition Analysis

21.1. Competition Dashboard

21.2. Competition Deep Dive (Company List)

21.2.1. Fagron

21.2.1.1. Overview

21.2.1.2. Product Portfolio

21.2.1.3. Profitability by Market Segments (Product/ Region)

21.2.1.4. Sales Footprint

21.2.1.5. Strategy Overview

21.2.1.5.1. Marketing Strategy

21.2.1.5.2. Product Strategy

21.2.2. Fresenius Kabi AG

21.2.2.1. Overview

21.2.2.2. Product Portfolio

21.2.2.3. Profitability by Market Segments (Product/ Region)

21.2.2.4. Sales Footprint

21.2.2.5. Strategy Overview

21.2.2.5.1. Marketing Strategy

21.2.2.5.2. Product Strategy

21.2.3. PharMEDium Services, LLC,

21.2.3.1. Overview

21.2.3.2. Product Portfolio

21.2.3.3. Profitability by Market Segments (Product/ Region)

21.2.3.4. Sales Footprint

21.2.3.5. Strategy Overview

21.2.3.5.1. Marketing Strategy

21.2.3.5.2. Product Strategy

21.2.4. Institutional Pharmacy Solutions

21.2.4.1. Overview

21.2.4.2. Product Portfolio

21.2.4.3. Profitability by Market Segments (Product/ Region)

21.2.4.4. Sales Footprint

21.2.4.5. Strategy Overview

21.2.4.5.1. Marketing Strategy

21.2.4.5.2. Product Strategy

21.2.5. Cantrell Drug Company

21.2.5.1. Overview

21.2.5.2. Product Portfolio

21.2.5.3. Profitability by Market Segments (Product/ Region)

21.2.5.4. Sales Footprint

21.2.5.5. Strategy Overview

21.2.5.5.1. Marketing Strategy

21.2.5.5.2. Product Strategy

21.2.6. Lorraine’s Pharmacy

21.2.6.1. Overview

21.2.6.2. Product Portfolio

21.2.6.3. Profitability by Market Segments (Product/ Region)

21.2.6.4. Sales Footprint

21.2.6.5. Strategy Overview

21.2.6.5.1. Marketing Strategy

21.2.6.5.2. Product Strategy

21.2.7. B. Braun Melsungen AG Company.

21.2.7.1. Overview

21.2.7.2. Product Portfolio

21.2.7.3. Profitability by Market Segments (Product/ Region)

21.2.7.4. Sales Footprint

21.2.7.5. Strategy Overview

21.2.7.5.1. Marketing Strategy

21.2.7.5.2. Product Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Table 01: Global Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Region

Table 02: Global Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type

Table 03: Global Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application

Table 04: Global Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area

Table 05: North America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Country

Table 06: North America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type

Table 07: North America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application

Table 08: North America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area

Table 09: Latin America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Country

Table 10: Latin America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type

Table 11: Latin America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application

Table 12: Latin America Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area

Table 13: Europe Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Country

Table 14: Europe Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type

Table 15: Europe Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application

Table 16: Europe Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area

Table 17: Asia Pacific Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Country

Table 18: Asia Pacific Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type

Table 19: Asia Pacific Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application

Table 20: Asia Pacific Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area

Table 21: MEA Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Country

Table 22: MEA Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Product Type

Table 23: MEA Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Application

Table 24: MEA Compounding Pharmacies Market Size (US$ Mn) Analysis 2016–2020 & Forecast 2021–2031, By Therapeutic Area